Reported
Lowest–highest estimate
The chart could not be loaded. Try again or view the figures below.
| Value | YoY | Lowest–highest | Analysts | |
|---|---|---|---|---|
BioMarin Pharmaceutical Inc
LSE:0HNC
BioMarin Pharmaceutical Inc
LSE:0HNC
Price:
59.3587
USD
-2.06%
Market Closed
Market Cap:
$11.4B
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
BioMarin Pharmaceutical Inc
LSE:0HNC
|
US |
|
W
|
Wynn Resorts Ltd
DUS:WYR
|
US |
|
Takeda Pharmaceutical Co Ltd
TSE:4502
|
JP |
|
T
|
Takeda Pharmaceutical Co Ltd
SWB:TKDA
|
JP |
|
Amerisafe Inc
NASDAQ:AMSF
|
US |
|
A
|
Applied Industrial Technologies Inc
F:AT4
|
US |
|
Standard Bank Group Ltd
OTC:SBGOF
|
ZA |
|
Central Garden & Pet Co
NASDAQ:CENT
|
US |
|
AIA Group Ltd
F:7A2S
|
HK |
|
N
|
Neste Oyj
XMUN:NEF
|
FI |
|
Assystem SA
PAR:ASY
|
FR |
|
F
|
Fresenius Medical Care AG
SWB:FMEA
|
DE |
|
T
|
Takeda Pharmaceutical Co Ltd
XMUN:TKD
|
JP |
Wall St Price Targets
0HNC Price Forecast
Based on 27 analysts
Based on 27 analysts
+54% Upside
from
$59.3587
today
BioMarin Pharmaceutical Inc (0HNC)’s 12-month stock price forecast through October 2027 has a consensus target of $91.5764, implying 54% upside. The forecast is based on price targets from 27 Wall Street analysts.
0HNC Analyst Rating
No ratings yet
No ratings yet
BioMarin Pharmaceutical Inc Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 0HNC's stock price target?
Price Target
91.5764
USD
91.5764
USD
According to Wall Street analysts, the average 1-year price target for 0HNC is 91.5764 USD with a low forecast of 60.4523 USD and a high forecast of 129.8828 USD.
What is the Revenue forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Revenue has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Gross Profit forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
8%
8%
Over the last 13 years, the compound annual growth rate for Gross Profit has been 15%. The projected CAGR for the next 8 years is 8%.
What is the Operating Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
14%
14%
The compound annual growth rate for Operating Income over the next 8 years is 14%.
What is the Pre-Tax Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
48%
48%
The compound annual growth rate for Pre-Tax Income over the next 3 years is 48%.
What is the Net Income forecast for BioMarin Pharmaceutical Inc?
Projected CAGR
24%
24%
The compound annual growth rate for Net Income over the next 8 years is 24%.